Nuformix (LON:NFX) Shares Up 5.1% – Here’s What Happened

Nuformix plc (LON:NFX) shares were up 5.1% during trading on Thursday . The stock traded as high as GBX 0.31 and last traded at GBX 0.31. Approximately 10,830,912 shares traded hands during mid-day trading, a decline of 43% from the average daily volume of 18,889,604 shares. The stock had previously closed at GBX 0.30.

Nuformix Price Performance

The firm’s fifty day moving average is GBX 0.28 and its two-hundred day moving average is GBX 0.21. The firm has a market cap of £6.41 million, a price-to-earnings ratio of -0.77 and a beta of 1.22.

Nuformix Company Profile

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications.